You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemo-induction

Showing 1 - 25 of 5,573
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Split-course hypo-CCRT
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Aug 26, 2023

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

Not yet recruiting
  • Pleural Mesothelioma
  • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
  • Rozzano, MI, Italy
  • +5 more
Nov 30, 2023

Lung Cancer, Non-small Cell Trial in Nanjing (hypofractionated radiation therapy)

Active, not recruiting
  • Lung Cancer, Non-small Cell
  • hypofractionated radiation therapy
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Mar 13, 2023

Head Neck Cancer, Larynx Trial in Lexington (Low dose fractionated radiation - 80cGy with chemo, Docetaxel and Carboplatin AUC

Active, not recruiting
Has Results
  • Head and Neck Cancer
  • Larynx
  • Low dose fractionated radiation - 80cGy with chemotherapy
  • Docetaxel and Carboplatin AUC 6
  • Lexington, Kentucky
    University of Kentucky, Markey Cancer Center
Aug 29, 2022

Immunotherapy in Locally Advanced or Oligometastatic NSCLC

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • induction therapy
  • Esslingen, Germany
    Klinikum Esslingen
Aug 15, 2022

Leukemia, MDS Trial in Gainesville (Diet)

Recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • Diet
  • Gainesville, Florida
    UF Health Cancer Center
Aug 9, 2022

Pancreatic Cancer Trial in Modena (LDR, Gem-based doublets, SBRT)

Recruiting
  • Pancreatic Cancer
  • LDR
  • +2 more
  • Modena, MO, Italy
    Azienda Ospedaliero-Universitaria Policlinico di Modena
Dec 8, 2022

HIV, Burkitt's Lymphoma Trial in Italy (Induction Phase, Consolidation Phase (on day +50), Intensification phase)

Completed
  • HIV
  • Burkitt's Lymphoma
  • Induction Phase
  • +4 more
  • Aviano (PN), Italy
  • +7 more
Aug 2, 2022

NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

Recruiting
  • Non-small Cell Lung Cancer
  • Hypofractionated radiotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Nov 14, 2023

SCLC Trial in Shanghai (Conventionally fractionated concurrent chemo-radiotherapy, Accelerated hypofractionated concurrent

Recruiting
  • SCLC
  • Conventionally fractionated concurrent chemo-radiotherapy
  • Accelerated hypofractionated concurrent chemo-radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Apr 26, 2021

Hodgkin Lymphoma, Adult Trial in United States (Brentuximab vedotin, ABVD)

Completed
Has Results
  • Hodgkin Lymphoma, Adult
  • Brentuximab vedotin
  • ABVD
  • Duarte, California
  • +5 more
Nov 8, 2021

Metastatic NSCLC Trial in France (Pembrolizumab before randomization, Chemotherapy, Pemetrexed)

Recruiting
  • Metastatic NSCLC
  • Pembrolizumab before randomization
  • +3 more
  • Aix-en-Provence, France
  • +37 more
Jul 26, 2022

NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
Sep 1, 2021

Head and Neck Squamous Cell Cancer Trial in Shreveport (Cetuximab)

Terminated
Has Results
  • Head and Neck Squamous Cell Cancer
  • Shreveport, Louisiana
    LSU Health Sciences Center
Sep 16, 2020

Squamous Cell Carcinoma of the Head and Neck Trial in Saint Louis (Abraxane, Cetuximab, Cisplatin)

Completed
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 21, 2020

Adult Acute Myeloid Leukemia, Adult Myelodysplastic Syndrome Trial in United States (Chemotherapy)

Completed
Has Results
  • Adult Acute Myeloid Leukemia
  • Adult Myelodysplastic Syndrome
  • Bozeman, Montana
  • +8 more
Feb 11, 2021

Nasopharyngeal Cancer, Chemo, Radiotherapy Trial in China (Camrelizumab plus chemo-radiotherapy, Chemo-radiotherapy alone)

Recruiting
  • Nasopharyngeal Cancer
  • +3 more
  • Camrelizumab plus chemo-radiotherapy
  • Chemo-radiotherapy alone
  • Guangzhou, Guangdong, China
  • +5 more
Sep 24, 2020

Neck Cancer Trial in Moscow (Pembrolizumab)

Recruiting
  • Neck Cancer
  • Moscow, Russian Federation
  • +2 more
Sep 21, 2022

Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B-cell Lymphoma Recurrent Trial in Italy (R-DHAP, Pola-R-DHAP)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma Refractory
  • Diffuse Large B-cell Lymphoma Recurrent
  • Alessandria, Italy
  • +39 more
Jul 28, 2023

Squamous Cell Carcinoma of Larynx Trial in São Paulo (carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v.

Recruiting
  • Squamous Cell Carcinoma of Larynx
  • carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v. on day 1, every 21 days for 3 cycles
  • +2 more
  • São Paulo, Brazil
    Beneficiencia Portuguesa de São Paulo/Hospital São José
Dec 22, 2022

Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

Not yet recruiting
  • Breast Cancer Triple Negative
  • +3 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    May 18, 2023

    NSCLC Stage III, KRAS P.G12C Trial in Spain (Sotorasib)

    Recruiting
    • Non-small Cell Lung Cancer Stage III
    • KRAS P.G12C
    • Badalona, Barcelona, Spain
    • +19 more
    Jul 6, 2022

    Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma (DLBCL)
    • Lanzhou, Gansu, China
      The First Hospital of Lanzhou University
    Oct 23, 2022

    Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

    Not yet recruiting
    • Small Cell Lung Carcinoma
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale Tumori
    Jan 19, 2023